Novartis taps Turkey for regional HQ, new plant; Eisai, Minophagen ink Targretin deal;

@FiercePharma: Bayer fails to block class-action status for 8 women's sex-discrimination claims--BloombergNews | Follow @FiercePharma

> Novartis ($NVS) will make Turkey its home base for central Asia, the Middle East and Africa, the company said, and plans to set up a new manufacturing plant there. Report

> Eisai granted Targretin rights in Asia, the Middle East and Eastern Europe to Minophagen Pharmaceutical, for an undisclosed up-front payment and milestones after that. Article

> Roche ($RHHBY) CEO Severin Schwan said he was disappointed at Illumina's ($ILMN) rejection of a sweetened bid and called on shareholders to vote for Roche's slate of directors. News

> Teva Pharmaceutical ($TEVA) shares jumped after it launched exclusive copies of Sanofi's ($SNY) blood pressure drugs Avapro and Avalide, on top of its new generic version of the narcolepsy drug Provigil acquired along with Cephalon last year. Item

> Now that FTC has approved the merger of Express Scripts and Medco Health Solutions, questions remain about its effects on drug prices for pharma and costs for consumers. More

> Switzerland's pharma ingredients maker Lonza named Richard Ridinger as its new CEO, aiming to move toward chemicals production. Story

> Long-term use of estrogen-only hormone drugs does increase breast-cancer risk, a study found, supplementing recent research by suggesting that less than 10 years of therapy did not pose a higher risk. Report

Biotech News

@FierceBiotech:  Apple emerges as 'dominant' life sciences IT player. Article | Follow @FierceBiotech

@JohnCFierce: Small trial "suggests " bapineuzumab reduces tau tangles in Alzheimer's. And guess what? No sign of clinical benefit. More | Follow @JohnCFierce

@RyanMFierce: AstraZeneca desperately needs to restock its pipeline, and chips away at the problem with this Amgen deal: Release | Follow @RyanMFierce

> Bayer bolsters blockbuster case for regorafenib with new PhIII data. More

> Stemline bets $50M IPO on a pair of cancer stem cell treatments. Story

> Google contributes to $14M round for fast-growing Adimab. News

Medical Devices News

@FierceMedDev: Good news for battle-worn firm? Olympus Gets Alliance Offers From Sony, Fujifilm, Terumo--Bloomberg Story | Follow @FierceMedDev

> Maquet, Siemens team up for hybrid OR. Item

> Biomet looks to score DePuy's trauma biz for $280M. Story

> Latest Illumina rejection stings Roche. Report

> MHRA urges docs to avoid some metal hips. News

Manufacturing News

> FDA says NuSil must get at root of contamination. More

> FDA creates new standard for cargo theft. Article

> Novasep drawing on €40 million to fund international expansion. Item

> Traditional meds pose tough challenge to manufacturing. Report

Biotech Research News

> Study: DNA sequencing dubious as disease prevention tool. Story

> Deadly mushroom defeats human pancreatic cancer in mice. News

> Australian team produces bone stem cells, no marrow required. More

> Stanford CD47 breakthrough fights tumors in multiple cancers. Item

And Finally... In a potential boon for allergy drug makers, but a bust for allergy sufferers, pollen season appears to be lengthening and strengthening. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.